Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exatecan Mesylate in Pediatric and Young Adult Ewing's Sarcoma, PNET, or DSRCT
NCT00055952Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2003
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of exatecan in Ewing sarcoma, primitive neuroectodermal tumor (PNET), desmoplastic small round cell tumor (DSRCT), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2003; status: completed.
02
Drugs
exatecan
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)desmoplastic small round cell tumor (DSRCT)
Beyond the preview
Go deeper on NCT00055952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055952.